Clinical trial
Safety and Efficacy Study of Glufosfamide in Previously Treated Advanced Soft…
NCT00441467 · Eleison Pharmaceuticals LLC., Industry · Completed
Key facts
| NCT number | NCT00441467 |
|---|---|
| Title | Safety and Efficacy Study of Glufosfamide in Previously Treated Advanced Soft Tissue Sarcoma |
| Official title | An Open-Label Phase 2 Study of the Efficacy and Safety of Glufosfamide in Previously Treated Advanced Soft Tissue Sarcoma |
| Lead sponsor | Eleison Pharmaceuticals LLC., Industry |
| Collaborators | Threshold Pharmaceuticals Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Soft Tissue Sarcoma |
| Intervention type | Drug |
| Interventions | Glufosfamide |
| Enrollment | 22 |
| Start date | Mar 1, 2007 |
| Primary completion | Oct 1, 2008 |
| Completion | Oct 1, 2008 |
| First posted | Mar 1, 2007 |
| Last update posted | Mar 25, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: